Alerts will be sent to your verified email
Verify EmailMEDIORG
Medicamen Organics
|
Vineet Laboratories
|
Kabra Drugs
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
7.97 % | 6.26 % | 65.41 % |
5yr average Equity Multiplier
|
3.29 | 3.18 | -11.28 |
5yr Average Asset Turnover Ratio
|
0.76 | 1.36 | 0.0 |
5yr Avg Net Profit Margin
|
3.89 % | 1.11 % | 0.0 |
Price to Book
|
0.0 | 2.82 | 1.62 |
P/E
|
11.89 | 0.0 | 0.0 |
5yr Avg Cash Conversion Cycle
|
-32.99 Days | 89.15 Days | 0.0 |
Inventory Days
|
70.3 Days | 66.38 Days | 0.0 |
Days Receivable
|
198.36 Days | 80.91 Days | 0.0 |
Days Payable
|
321.34 Days | 81.06 Days | 0.0 |
5yr Average Interest Coverage Ratio
|
3.25 | 2.14 | -836.53 |
5yr Avg ROCE
|
15.06 % | 14.46 % | 64.57 % |
5yr Avg Operating Profit Margin
|
9.86 % | 3.72 % | 0.0 |
5 yr average Debt to Equity
|
1.18 | 0.69 | -6.16 |
5yr CAGR Net Profit
|
51.57 % | n/a | 65.28 % |
5yr Average Return on Assets
|
2.68 % | 1.2 % | -21.32 % |
Shareholdings
|
|||
Promoter Holding
|
59.73 % | 29.26 % | 0.0 |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.04 % | -6.7 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Medicamen Organics
|
Vineet Laboratories
|
Kabra Drugs
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|